CAPTRUST Financial Advisors
CGTX icon

CAPTRUST Financial Advisors’s Cognition Therapeutics CGTX Stock Holding History

CAPTRUST Financial Advisors’s Portfolio CGTX Stock Details CGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-50,000
Closed -$95K – 2081
2022
Q3 		$95K Buy
+50,000
New +$104K ﹤0.01% 1939

Other funds holding CGTX

ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return
CC
Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return
PWM
Perigon Wealth Management San Francisco, California $5.51B AUM 24.51% 1-Year Est. Return
AFG
American Financial Group Cincinnati, Ohio $270M AUM 3.25% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
VC
Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

CAPTRUST Financial Advisors's CGTX Position: Q4 2022 in Review

CAPTRUST Financial Advisors sold out of Cognition Therapeutics (CGTX) in Q4 2022, closing a stake of 50,000 shares — an estimated $95K sold.

CAPTRUST Financial Advisors first reported a position in CGTX in Q3 2022 and held it in 1 quarter. The position peaked at $95K in Q3 2022. 34 funds tracked by Wall St. Rank hold CGTX as of Q4 2022.

  • CAPTRUST Financial Advisors reported no remaining Cognition Therapeutics position as of Q4 2022 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 50,000 Cognition Therapeutics shares in Q4 2022, an estimated $95K.
  • CAPTRUST Financial Advisors first reported a position in Cognition Therapeutics in Q3 2022 and held it in 1 quarter.
  • CAPTRUST Financial Advisors's Cognition Therapeutics position peaked at $95K in Q3 2022.
  • 34 funds tracked by Wall St. Rank held Cognition Therapeutics as of Q4 2022.

Based on CAPTRUST Financial Advisors's 13F filing for Q4 2022, filed 15 Feb 2023.